Universe Pharmaceuticals ...

AI Score

0

Unlock

0.12
-0.01 (-6.03%)
At close: Mar 03, 2025, 3:59 PM
0.13
11.78%
After-hours: Mar 03, 2025, 05:45 PM EST

Company Description

Universe Pharmaceuticals INC, a pharmaceutical company, engages in the manufacture, marketing, distribution, and sale of traditional Chinese medicine derivative products in China.

It offers products for the treatment of common chronic health conditions in the elderly for physical wellness and longevity; and cold and flu medications.

The company also distributes and sells third-party producers, including biomedical drugs, medical instruments, traditional Chinese medicine pieces products, and dietary supplements.

Its customers include pharmaceutical companies, hospitals, clinics, and drugstore chains.

The company was incorporated in 2019 and is based in Ji'An, China.

Universe Pharmaceuticals INC is a subsidiary of Sununion Holding Group Limited.

Universe Pharmaceuticals INC
Universe Pharmaceuticals INC logo
Country CN
IPO Date Mar 23, 2021
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 225
CEO Gang Lai

Contact Details

Address:
No. 265, Jingjiu Avenue
Ji'An,
CN
Website https://www.universe-pharmacy.com

Stock Details

Ticker Symbol UPC
Exchange NASDAQ
Fiscal Year October - September
Reporting Currency USD
CIK Code 0001809616
CUSIP Number G9442G104
ISIN Number KYG9442G1120
Employer ID 00-0000000
SIC Code 2834

Key Executives

Name Position
Gang Lai Chief Executive Officer & Chairman
Baochang Liu Chief Operating Officer
Lin Yang Chief Financial Officer & Director

Latest SEC Filings

Date Type Title
Feb 25, 2025 6-K Filing
Feb 20, 2025 6-K Filing
Feb 18, 2025 6-K Filing
Feb 14, 2025 SCHEDULE 13G Filing
Feb 11, 2025 6-K Filing
Feb 03, 2025 6-K Filing
Jan 30, 2025 6-K Filing
Jan 27, 2025 NT 20-F Filing
Jan 03, 2025 SCHEDULE 13G Filing
Dec 12, 2024 6-K Filing